[8] [9] [10] [11] Although reduced GLP-1 secretion has previously been associated with attenuated incretin effect in patients with type 2 diabetes, further research indicates that GLP-1 secretion in patients with type 2 diabetes does not differ from healthy subjects
Adverse reactions to drugs medicines guidance, BNF NICE
We recommend that patients take these medications only for their approved indications and under the strict supervision of a healthcare professional, who can also advise on potential side effects."
Use of iGlarLixi for management of type 2 diabetes in Japanese clinical practice: SPARTA Japan, a retrospective observational study
It isn't some foreign substance
When choosing between programs, consider whats most important to youquick access to prescriptions or a more comprehensive, provider-led approach to your health goals